Filters
Regulatory approval of Hikma’s colchicine is upheld
Press Release, Corporate
Hikma announces launch of Generic Xeloda® Tablets 150 mg and 500 mg in the US
Press Release, Product
Hikma Pharmaceuticals to participate in the world economic forum's industry strategy meeting
Press Release, Responsibility
Hikma acquires six injectable products in Europe
Press Release, Corporate
Hikma receives FDA approval for Ketamine Hydrochloride Injection
Press Release, Product
Hikma announces FDA approval and launch of Fluticasone 50 MCG Spray, the store brand equivalent of Flonase
Press Release, Product
Michael Raya, CEO of West-Ward Pharmaceuticals, Hikma's wholly-owned subsidiary in the US, joins GPhA
Press Release, Corporate
HIKMA wins Mitigare / Colchicine patent infringement case
Press Release, Corporate
Hikma receives Drug Shortage Assistance Award from US FDA
Press Release, Product
Hikma receives FDA approval for Leucovorin Calcium Injection
Press Release, Product
Hikma receives FDA approval for Fluphenazine Decanoate Injection
Press Release, Product
Hikma Pharmaceuticals Celebrates ninth annual global volunteering day
Press Release, Responsibility
Hikma’s ANDA for Generic Advair Diskus® accepted for filing by FDA
Press Release, Corporate
Hikma’s ANDA for Generic Advair Diskus® accepted for filing by FDA (1)
Press Release, Product